EARNINGS: CRISM, Ampeak and Ethtry widen 2025 pretax loss
The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News:
----------
CRISM Therapeutics Corp - British Virgin Islands-based pharmaceutical firm - Reports no revenue for 2025, unchanged from 2024, while pretax loss widens to £1.9 million from £593,000 as administrative and other expenses increase to £2.0 million from £901,000. The company highlights regulatory progress, including UK approval for its phase 2 glioblastoma trial, and says it is well funded following recent equity raises and grant awards. CRISM expects to begin patient recruitment after a planned site initiation visit in late July and remains focused on advancing its phase 2 programme and broader ChemoSeed platform.
----------
Ampeak Energy Ltd- Edinburgh, Scotland-based developer, owner and operator of sustainable energy projects - Reports 2025 revenue rose to £15.0 million from £13.7 million, while pretax loss widened to £19.1 million from £12.6 million, reflecting continued investment in its battery storage business. The company says it is encouraged by progress and expects first commercial operations at its AW1 project in the first quarter of 2027. It forecasts average annual project revenue of £13 million and Ebitda of £9 million over the first five years of operations, adding that its battery energy storage pipeline has an enterprise value of more than £1 billion.
----------
Thruvision Group PLC - Abingdon, England-based provider of walkthrough people-screening technology - Reports a narrower annual loss as revenue rose 45% to £6.0 million from £4.2 million, driven by strong demand in Asia, including £2.7 million of material orders. Pretax and operating losses narrowed to £3.6 million from £4.7 million, while the loss per share improved to 1.01p from 2.81p. The firm ended the year with £2.0 million in cash and no debt, and says a strong order backlog and improved sales momentum give it confidence of further growth in financial 2027.
----------
Baillie Gifford UK Growth Trust PLC - London-based investment firm focused on capital growth over the long-term from investment primarily in shares of listed UK companies - Reports annual net asset value total return of 15.6%, trailing the FTSE All-Share index’s 25.2%, as the portfolio’s lack of exposure to oil & gas, mining and banks weighed on performance. Net asset value per share rises to 226.7 pence at April 30 from 201.2p a year earlier. The trust recommends a final dividend of 6.20p per share, up from 5.70p, while Baillie Gifford will reduce its management fee to 0.40% from 0.50% between July 2026 and April 2029. Chair Neil Rogan says the board remains focused on improving performance ahead of a 2027 continuation vote and a 2029 performance-triggered tender offer.
----------
Kistos Holdings PLC - London-based oil and gas producer from offshore and onshore assets in the UK, Norway, and the Netherlands - Revenue in 2025 slips to $212.9 million from $216.3 million, although adjusted Ebitda rises to $96.6 million from $95.3 million as production increases to 8,940 barrels of oil equivalent per day from 8,050 boepd. The company maintains 2026 production guidance of 19,000 to 21,000 boepd and says it continues to evaluate value-accretive acquisition opportunities across the Middle East, North Africa and Europe.
----------
Ethtry PLC - London-based company building ethereum treasury for investments in ‘breakthrough technologies’ - Pretax loss for 2025 widens to £619,270 from £251,521 a year earlier, as administrative expenses increase to £491,079 from £258,127. Loss per share narrows, however, to 0.14 pence from 0.28p following a higher share count after fundraising. During the year, the company rebranded from Igraine, raised £5.3 million and adopted an Ethereum treasury policy. Since the year-end, it has built holdings of 1,000 ethereum, entered partnerships with AMINA Bank and Liechtenstein Trust Integrity Network, and invested £500,000 in a senior secured lending facility for offshore wind developer Cerulean Winds.
----------
Deltic Energy PLC - London-based investment firm with an exploration and appraisal portfolio in the southern and central North Sea - Reports its 2025 pretax loss narrows to £2.2 million from £21.2 million a year earlier, while administrative expenses fall sharply to £1.9 million from £21.4 million and loss per share narrows to 2.30 pence from 22.82p. The company ends the year with £1.6 million in cash and says shareholders have approved its recommended takeover by Neo Next+, which is expected to complete in the coming months, subject to regulatory approval. Deltic warns there is material uncertainty over its ability to continue as a going concern if the acquisition does not complete, as it would require additional funding to meet deferred payment obligations and continue operations.
----------
Arc Minerals Ltd - copper exploration company focused on mines in Africa - Reports its 2025 pretax loss widened to £9.1 million from £2.1 million, as administrative expenses increased to £2.3 million from £1.1 million and it booked a £6.7 million accounting charge related to the acquisition of Handa Resources. The company says it remains well placed to generate significant value as it advances its portfolio, supported by ongoing exploration and development activities.
----------
AEW UK REIT PLC - Leeds, England-based real estate investment trust - Reports net asset value per share fell 1.4% to 108.38 pence at March 31 from 110.11p a year earlier, with NAV total return declining to 5.7% from 15.0%. The property investor maintained its total annual dividend at 8.0p per share, while its cash balance fell to £15.2 million from £27.8 million after capital deployment. AEW UK REIT says UK property pricing remains attractive and, despite macroeconomic uncertainty, believes the current opportunity is to continue deploying capital.
----------
Copyright 2026 Alliance News Ltd. All Rights Reserved.